Altamura S - Search Results

1

Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model.

Bregolat NF, Ruetten M, Da Silva MC, Aboouf MA, Ademi H, Büren NV, Armbruster J, Stirn M, Altamura S, Marques O, Rodriguez JMM, Samillan VJ, Singh RP, Wielockx B, Muckenthaler MU, Gassmann M, Thiersch M. Bregolat NF, et al. Among authors: altamura s. Haematologica. 2022 Oct 1;107(10):2454-2465. doi: 10.3324/haematol.2022.280732. Haematologica. 2022. PMID: 35385924 Free PMC article.

2

Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD.

Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU. Casanovas G, et al. Among authors: altamura s. J Mol Med (Berl). 2009 May;87(5):471-80. doi: 10.1007/s00109-009-0447-2. Epub 2009 Feb 20. J Mol Med (Berl). 2009. PMID: 19229506

3

Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.

Altamura S, Muckenthaler MU. Altamura S, et al. J Alzheimers Dis. 2009;16(4):879-95. doi: 10.3233/JAD-2009-1010. J Alzheimers Dis. 2009. PMID: 19387120 Review.

4

SELDI-TOF MS detection of urinary hepcidin.

Altamura S, Kiss J, Blattmann C, Gilles W, Muckenthaler MU. Altamura S, et al. Biochimie. 2009 Oct;91(10):1335-8. doi: 10.1016/j.biochi.2009.04.010. Epub 2009 Apr 22. Biochimie. 2009. PMID: 19393287

5

A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.

Altamura S, D'Alessio F, Selle B, Muckenthaler MU. Altamura S, et al. Biochem J. 2010 Nov 1;431(3):363-71. doi: 10.1042/BJ20100668. Biochem J. 2010. PMID: 20704562 Free PMC article.

6

The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice.

Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, Stolte J, Sparla R, D'Alessandro LA, Klingmüller U, Fleming RE, Longerich T, Gröne HJ, Benes V, Kauppinen S, Hentze MW, Muckenthaler MU. Castoldi M, et al. Among authors: altamura s. J Clin Invest. 2011 Apr;121(4):1386-96. doi: 10.1172/JCI44883. J Clin Invest. 2011. PMID: 21364282 Free PMC article.

7

Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.

Casanovas G, Swinkels DW, Altamura S, Schwarz K, Laarakkers CM, Gross HJ, Wiesneth M, Heimpel H, Muckenthaler MU. Casanovas G, et al. Among authors: altamura s. J Mol Med (Berl). 2011 Aug;89(8):811-6. doi: 10.1007/s00109-011-0751-5. Epub 2011 Apr 8. J Mol Med (Berl). 2011. PMID: 21475976

8

Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C.

Ryan JD, Altamura S, Devitt E, Mullins S, Lawless MW, Muckenthaler MU, Crowe J. Ryan JD, et al. Among authors: altamura s. Hepatology. 2012 Aug;56(2):492-500. doi: 10.1002/hep.25666. Epub 2012 Jun 11. Hepatology. 2012. PMID: 22334511 Clinical Trial.

9

Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients.

Lehmberg K, Grosse R, Muckenthaler MU, Altamura S, Nielsen P, Schmid H, Graubner U, Oyen F, Zeller W, Schneppenheim R, Janka GE. Lehmberg K, et al. Among authors: altamura s. Ann Hematol. 2013 Mar;92(3):387-94. doi: 10.1007/s00277-012-1618-8. Epub 2012 Nov 20. Ann Hematol. 2013. PMID: 23180434

10

Reply: To PMID 22334511.

Ryan JD, Altamura S, Muckenthaler M, Crowe J. Ryan JD, et al. Among authors: altamura s. Hepatology. 2014 Apr;59(4):1648-9. doi: 10.1002/hep.26764. Epub 2014 Feb 14. Hepatology. 2014. PMID: 24122806 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page